Welcome to PsychU!
Menu

Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD.

Featuring

Becky-Wong

Becky Wong, PharmD, MBA

Medical Science Director

E. Jeffrey-Greenberg

E. Jeffrey Greenberg, MD

Neurologist at Princeton & Rutgers Neurology, P.A., Co-Founder of Advanced Clinical Institute

More
Jaclyn-Beckinghausen

Jaclyn Beckinghausen

Becky Wong, PharmD, MBA and Jaclyn Beckinghausen are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

E. Jeffrey Greenberg, MD is a paid speaker for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Log in to register

Related Resources

Join today for instant access to all PsychU content, events, and more!

Membership is free!

"*" indicates required fields

Name*
Zip / Postal Code*

Choose Your Unique Login

Your username can only contain lowercase letters (a-z) and numbers. Username cannot be the same as email address.
Email*
Password*
Your password must be at least 8 characters Hint: Must use combination of lower case letters, upper case letters, numbers and special characters like !@#$.

I AGREE TO THE FOLLOWING TERMS

I agree to the following terms:*
I agree to the following terms*
Hidden
Hidden
Hidden
Hidden